This inventor holds 4 USPTO granted patents and 2 published patent applications and 8 EPO patents. Top assignees: Jiangsu Alphamab Biopharmaceuticals Co., Ltd., Dingfu Biotarget Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
1 out of 1 
1 out of 7 Years Active: 2025-2026
Title: Ting Xu: Innovator in Tumor Treatment
Introduction
Ting Xu is a prominent inventor based in Suzhou, China. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative methods for treating tumors. Her work focuses on utilizing anti-CTLA4 single-domain antibodies to combat cancer effectively.
Latest Patents
Ting Xu holds a patent for a method of treating tumors using a CTLA4-binding protein. This method involves a CTLA4-binding protein that specifically binds to CTLA4 without competing with its ligand. The innovative approach described in her patent can effectively inhibit tumor growth, showcasing her commitment to advancing cancer treatment.
Career Highlights
Throughout her career, Ting Xu has worked with notable companies in the biopharmaceutical sector. She has been associated with Jiangsu Alphamab Biopharmaceuticals Co., Ltd. and Dingfu Biotarget Co., Ltd. Her experience in these organizations has contributed to her expertise in developing groundbreaking therapeutic methods.
Collaborations
(Section skipped due to space constraints)
Conclusion
Ting Xu's innovative work in tumor treatment exemplifies her dedication to improving cancer therapies. Her patent and career achievements highlight her role as a leading inventor in the biopharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile